Search results
Older people and pregnant women to be offered new NHS respiratory virus jab
Press Association News via AOL· 8 hours agoDr Conall Watson, consultant epidemiologist at the UK Health Security Agency, said: “We encourage...
Pregnant women and elderly to be offered respiratory virus jab on NHS
Daily Telegraph· 7 hours agoThe new NHS vaccine programmes in England are expected to be delivered through GP surgeries and...
Britain snubs GSK in favour of US pharma giant for RSV vaccine
The Telegraph via Yahoo News· 1 day agoThe NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against...
Glenn Close ‘hit hard’ with Covid and RSV at same time, forced to delay filming ‘Knives Out 3’ | CNN
CNN.com· 6 days agoRespiratory syncytial virus, known as RSV, is a common respiratory virus that typically causes...
UK Government Snubs GSK in Favor of Pfizer’s Rival RSV Shot
Bloomberg· 1 day agoHave a confidential tip for our reporters? GSK Plc has lost out to Pfizer Inc. on a contract to...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 5 days agoThe firm's decision follows the U.S. Food and Drug Administration's (FDA) approval of Moderna's...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 5 days agoBut, keep in mind, sales are still falling and the company continues reporting losses. And analysts...
Boost your immune system with this centuries-old health hack: Vaccines
The Conversation via Yahoo News· 5 days agoVaccine-preventable diseases are still common. In the U.S., hundreds of thousands of adults are...
Gateway - Quartz
Quartz· 7 days agoModerna stock jumped 7% during premarket trading on Thursday after the pharma company, known for its mRNA COVID-19 vaccine, reported a profit of $217 million in its fourth ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. -...
CW39 NewsFix· 21 hours agoPomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to contact Danielle Peyton at newaction@ ...